This finding has exciting implication for developing a vaccine against AIDS. Before this, scientists have been unsuccessful in trying to produce a strain of HIV that is harmless but can ilicit an immune response. The Australian strain with the defective nef gene has the potential to be used in a vaccine that would arm the immune system against this and other strains of HIV.
Another application of this discovery is its use in developing drugs that inhibit gene products that increase the virus's replication. It seems that the protein produced from the nef gene is one of these critical gene products, because viruses with defective forms of nef do not reproduce much, as in the cases of the six Australians. Research is currently underway to develop a drug that targets the nef protein.
Source: "AIDS Virus's Genetic Armor May Have a Vulnerable Spot" by Lawrence K. Altman, New York Times, November 10, 1995